Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.98 USD | -17.31% | -18.26% | -41.33% |
May. 23 | Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating | MT |
May. 23 | Sector Update: Health Care Stocks Flat to Lower Premarket Thursday | MT |
Business Summary
Number of employees: 423
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Muscle Activators
100.0
%
| 95 | 100.0 % | 8 | 100.0 % | -92.04% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 95 | 100.0 % | 8 | 100.0 % | -92.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 98-06-30 |
Kari Loeser
CMP | Compliance Officer | - | 21-10-31 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Daniel Casper
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Fady Malik
CTO | Chief Tech/Sci/R&D Officer | 59 | 97-12-31 |
Eric Terhaerdt
COO | Chief Operating Officer | - | 18-12-31 |
Diane Weiser
IRC | Investor Relations Contact | - | 15-03-31 |
John Faurescu
LAW | General Counsel | - | - |
Yulymae Dinapoli
HRO | Human Resources Officer | - | 21-10-31 |
Jeff Lotz
SAM | Sales & Marketing | - | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 20-11-19 |
Edward Kaye
BRD | Director/Board Member | 75 | 16-05-19 |
Santo Costa
BRD | Director/Board Member | 78 | 10-09-30 |
B. Parshall
BRD | Director/Board Member | 70 | 13-02-06 |
Wendell Wierenga
BRD | Director/Board Member | 76 | 11-02-08 |
John Henderson
CHM | Chairman | 79 | 09-01-31 |
Robert Blum
CEO | Chief Executive Officer | 60 | 98-06-30 |
Director/Board Member | 63 | 22-04-07 | |
Muna Bhanji
BRD | Director/Board Member | 61 | 21-02-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 104,853,918 | 104,229,391 ( 99.40 %) | 0 | 99.40 % |
Company contact information
Cytokinetics, Inc.
350 Oyster Point Boulevard
94080, South San Francisco
+650 624 3000
http://www.cytokinetics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.33% | 5.62B | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.29% | 21.58B | |
-11.39% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- CYTK Stock
- Company Cytokinetics, Incorporated